SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 32 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $8,162,000 | +681.8% | 4,471,000 | +935.0% | 0.90% | +666.9% |
| Q3 2014 | $1,044,000 | -83.4% | 432,000 | -86.5% | 0.12% | -84.1% |
| Q2 2014 | $6,290,000 | -19.1% | 3,200,000 | -30.5% | 0.74% | -12.2% |
| Q1 2014 | $7,777,000 | -20.8% | 4,605,000 | -30.2% | 0.84% | -20.4% |
| Q4 2013 | $9,814,000 | +21.6% | 6,595,000 | +0.6% | 1.06% | +12.2% |
| Q3 2013 | $8,071,000 | +12.1% | 6,555,000 | +9.1% | 0.95% | +7.9% |
| Q2 2013 | $7,197,000 | – | 6,010,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALTEGRIS ADVISORS, L.L.C. | 1,000,000 | $1,491,000 | 14.69% |
| Sage Capital Management, LLC | 3,000,000 | $4,489,000 | 4.80% |
| GRACE BROTHERS MANAGEMENT LLC | 2,000,000 | $2,993,000 | 2.50% |
| Wellesley Asset Management | 22,664 | $33,971,000 | 2.40% |
| MACKAY SHIELDS LLC | 31,509,000 | $47,101,000 | 1.77% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 18,000,000 | $26,828,000 | 1.23% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $12,407,000 | 1.14% |
| Calamos Wealth Management LLC | 2,362,000 | $3,546,000 | 1.09% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,595,000 | $9,814,000 | 1.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 36,808,000 | $54,620,000 | 1.00% |